Melanoma News & Features
T cells from patients with melanoma can trigger a protective immune response against the disease.
A novel mechanism has been discovered that can lead melanoma cells to develop resistance to drugs that target the protein BRAF.
Using drugs for impotence does not increase the risk of malignant melanoma, according to recent research that contradicts some earlier findings.
Researchers suspect compounds in citrus may sensitize skin to sunlight and thereby increase melanoma risk, but further study is required.
Slightly higher odds of melanoma for men on erectile dysfunction (ED) drugs were recorded, but lifestyles are probable culprit.
- Protein associated with spread of osteosarcoma
- Multiple myeloma uses "wolf in sheep's clothing" tactic to avoid immune response in bone
- Comparison of zoledronic acid dosing schedules finds less frequent schedule noninferior
- HPV16 detection after oropharyngeal cancer treatment may increase risk for recurrence
- Delayed referrals, diagnoses undermine cancer patients' faith in health care system
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|